Malignant mesothelioma of the peritoneum invading the liver and mimicking metastatic carcinoma: A case report

Pathology Research and Practice

Volumn 207, Issue 6, 2011, Pages 395-398

  Nagata, Shigenori ^a   Tomoeda, Miki ^a   Kubo, Chiaki ^a   Yoshizawa, Hidenori ^a   Yuki, Michiko ^a   Kitamura, Masanori ^a   Takenaka, Akemi ^a   Nakanishi, Katsuyuki ^a   Yagi, Toshiya ^a   Imamura, Fumio ^a   Tomita, Yasuhiko ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Cancer of unknown primary site; Liver invasion; Malignant peritoneal mesothelioma

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALDESMON; CALRETININ; CYTOKERATIN; HEMOGLOBIN; INTERLEUKIN 2 RECEPTOR; PARAFFIN; PODOPLANIN; TUMOR ANTIGEN;

ADENOCARCINOMA; ADULT; ANEMIA; ARTICLE; ASCITES; BILE DUCT CARCINOMA; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER METASTASIS; LYMPHADENOPATHY; PERITONEAL CAVITY; PERITONEUM MESOTHELIOMA; PLEURA EFFUSION; PROTEIN BLOOD LEVEL;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MESOTHELIOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79958718237     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.04.004     Document Type: Article

References (15)

1. Attanoos R.L., Gibbs A.R. Pathology of malignant mesothelioma. Histopathology 1997, 30:403-418.
2. Baker P.M., Clement P.B., Young R.H. Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Am. J. Clin. Pathol. 2005, 123:724-737.
3. Chu C.M., Lin S.M., Peng S.M., Wu C.S., Liaw Y.F. The role of laparoscopy in the evaluation of ascites of unknown origin. Gastrointest. Endosc. 1994, 40:285-289.
4. Churg A., Cagle P.T., Roggli V.L. Diffuse malignant tumors of the serosal membranes. AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Serosal Membranes 2006, 33-82. ARP Press, Silver Spring, MD, USA. A. Churg, P.T. Cagle, V.L. Roggli (Eds.).
5. Comin C.E., Saieva C., Messerini L. h-Caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am. J. Surg. Pathol. 2007, 31:1139-1148.
6. Daskalogiannaki M., Prassopoulos P., Raissaki M., Tsardi M., Gourtsoyiannis N. Malignant peritoneal mesothelioma presenting with respiratory symptoms. Eur. Radiol. 2000, 10:814-816.
7. Durnez A., Verslype C., Nevens F., Fevery J., Aerts R., Pirenne J., Lesaffre E., Libbrecht L., Desmet V., Roskams T. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006, 49:138-151.
8. Heatley M.K. Sister Mary Joseph's nodule in malignant mesothelioma. Histopathology 2004, 45:299-300.
9. Husain A.N., Colby T.V., Ordóñez N.G., Krausz T., Borczuk A., Cagle P.T., Chirieac L.R., Churg A., Galateau-Salle F., Gibbs A.R., Gown A.M., Hammar S.P., Litzky L.A., Roggli V.L., Travis W.D., Wick M.R. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch. Pathol. Lab. Med. 2009, 133:1317-1331.
10. Levy A.D., Arnáiz J., Shaw J.C., Sobin L.H. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics 2008, 28:583-607.
11. Sadeghi B., Arvieux C., Glehen O., Beaujard A.C., Rivoire M., Baulieux J., Fontaumard E., Brachet A., Caillot J.L., Faure J.L., Porcheron J., Peix J.L., François Y., Vignal J., Gilly F.N. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000, 88:358-363.
12. Schneiderman H. Mesothelioma and venous thrombosis. CMAJ 2004, 171:11.
13. Sugarbaker P.H., Acherman Y.I., Gonzalez-Moreno S., Ortega-Perez G., Stuart O.A., Marchettini P., Yoo D. Diagnosis and treatment of peritoneal mesothelioma: the Washington Cancer Institute experience. Semin. Oncol. 2002, 29:51-61.
14. Takeshima Y., Amatya V.J., Kushitani K., Inai K. A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases. Am. J. Clin. Pathol. 2008, 130:771-779.
15. Uenishi T., Kubo S., Yamamoto T., Shuto T., Ogawa M., Tanaka H., Tanaka S., Kaneda K., Hirohashi K. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003, 94:851-857.